Newbridge Financial Services Group, Inc. Chimerix Inc Transaction History
Newbridge Financial Services Group, Inc.
- $372 Million
- Q4 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Chimerix Inc stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 2,500 shares of CMRX stock, worth $10,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$10,950
Previous $2,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
75Shares Held
36.7MCall Options Held
182KPut Options Held
108K-
Ra Capital Management, L.P. Boston, MA8.8MShares$38.5 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.04MShares$17.7 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$16.5 Million0.32% of portfolio
-
Monaco Asset Management Sam2.82MShares$12.4 Million1.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.56MShares$11.2 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $384M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...